Pfizer Beats Forecasts as Vaccine Trial Enters Final Stage – The Wall Street Journal

Pfizer Inc. reported growth in its biopharma division in the latest quarter, but overall sales fell amid increased competition in its generic-drug business.

The New York City-based pharmaceutical company reported revenue of $11.8 billion, an 11% decline from $13.3 billion a year earlier. Analysts’ consensus had forecast sales of $11.58 billion,…